-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Xetra FrankfurtISIN US717081ER06-
PfizerBörse NYSE New York Stock ExchangeISIN US7170811035 WKN: 852009Symbol PFE
-
PFIZER INCBörse Börse HamburgISIN US717081ED10Symbol PFE
-
PfizerBörse Börse StuttgartISIN US717081DK61Symbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081ER06Symbol PFE
-
PFIZER INCBörse Börse DüsseldorfISIN XS1574158082Symbol PFE
-
PFIZER INCBörse Börse MünchenISIN US717081DZ31Symbol PFE
-
PFIZER INCBörse Gettex System der Börse MünchenISIN US717081ES88Symbol PFE
-
PFIZER INCBörse Tradegate System der Deutsche Börse AG (60%)ISIN US717081EQ23Symbol PFE
-
PFIZER INCBörse Quotrix System der Börse DüsseldorfISIN US717081DE02Symbol PFE
-
PFIZER INCBörse Börse FrankfurtISIN XS1574157357Symbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081EY56
-
PfizerBörse Börse MünchenISIN US717081FA61
-
PfizerBörse SSE Stockholm Stock ExchangeISIN US717081EZ22Symbol PFE
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081EK52Symbol PFE
-
PfizerBörse Bolsa de Comercio de Buenos AiresISIN US717081DV27
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081DH33
-
PfizerBörse BUEISIN US717081EV18
-
ISIN US717081EX73Symbol PFE
-
PfizerBörse OMXSISIN US7170811035
-
ISIN US717081EJ89
-
PFIZER INCBörse SSEISIN US717081EP40
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
204.882.624.512 oder 216.419.000.000 oder 171.198.615.249
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88.300 oder 78.500 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23.97 oder 13.4
Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Letzte Communitymeinungen
- 2 User waren zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
casixxx
-
Harry386
Ein User hat Pfizer abonniert.
Aktionärsstruktur der Pfizer Inc
Portrait der Pfizer Aktie
Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.
Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
1.790 News & Informationen zur Pfizer Aktie
Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Moderna Gains As UK Regulator Oks Covid Shot For Those Aged 12–17 By Investing.com
Moderna Gains As UK Regulator Oks Covid Shot For Those Aged 12–17
Moderna Stock At $400. What Are The Risks?
Moderna stock is up by about 2.5x year-to-date, trading at levels of about $390 per share as of Friday. The rally comes on the back of Moderna’s recent inclusion into the S&P 500 index and the emergence of new virus variants which are making a strong case for booster doses of Covid-19 shots…
Pfizer (PFE)/BioNTech Give First COVID Jab Booster Data to FDA
Pfizer (PFE)/BioNTech's (BNTX) booster dose of COVID-19 vaccine elicited antibody levels that were much higher than that seen after the two-dose primary schedule.
SEC Charges Biopharmaceutical Company Employee with Insider Trading
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs.
Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market …
Biden set to urge Covid-19 booster shots starting next month
Biden administration is finalizing a plan expected to recommend Covid-19 booster shots eight months after people received their second dose. The plan is not yet finalized but an announcement could come as soon as this week
15 Best Momentum Stocks To Invest In
The influx of retail investors on the market in the past few months has led to an increase in stock volatility.
U.K. Authorizes Moderna Covid-19 Vaccine for Use in Adolescents
(Bloomberg) — Britain’s drug regulator authorized Moderna Inc.’s Covid-19 shot for children as young as 12, though few are likely to receive it in the near term as the country remains an outlier in its policy on vaccinating kids.
The U.K.
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
No data shows need for booster vaccines presently: Dr Gagandeep Kang
Read more about No data shows need for booster vaccines presently: Dr Gagandeep Kang on Business Standard. According to Dr Kang, whether people will have more antibodies or be better protected with the booster dose is still not known
New Zealand to enter lockdown; Japan set to expand emergency
New Zealand Prime Minister Jacinda Ardern put the nation into a three-day lockdown after reporting the first community case of Covid since February. The country will be placed in lockdown at midnight tonight after discovery of a single case in Auckland, Ardern said at a news conference in Wellington. Auckland…
5 things to know before the stock market opens Tuesday
Stock futures fell Tuesday morning as traders awaited the release of key economic data about the U.S. consumer.
If you have taken a Pfizer Covid-19 vaccine – here’s what you should know about a third ‘booster’ shot
Pharmaceutical companies Pfizer and BioNTech have submitted data to the US Food and Drug Administration (FDA) to support the evaluation of a third booster shot…
HK Raises Quarantine Time; New Zealand Local Case: Virus Update
(Bloomberg) — Hong Kong will hike quarantine for medium-risk places to 14 days to curb the spread of the virus. Business groups in the city are already…
Wyeth sets repurchase price at Rs1,284.18 per share
The company intends to repurchase 396,579 shares comprising 27.90 per cent of the capital of the company.
Pfizer, BioNTech Submit COVID-19 Booster Vaccine Data To FDA
(RTTNews) – Pfizer Inc. (PFE) and BioNTech SE (BNTX) have submitted phase 1 data to the U.S. Food and Drug Administration to support the evaluatio…
Pfizer submits initial data for COVID-19 vaccine booster authorization
They said the third dose showed significantly higher neutralizing antibodies against the initial SARS-CoV-2 virus compared to the two doses as well as against the Beta and the highly infectious Delta variants.
Pfizer: The Rally Is Far From Finished
GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.
Pfizer: The Rally Is Far From Finished
GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.
Pfizer: The Rally Is Far From Finished
GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.
Pfizer: The Rally Is Far From Finished
GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.
Pfizer: The Rally Is Far From Finished
GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.
Mayo Investment Advisers Llc Buys Vertex Pharmaceuticals Inc, Vistra Corp, Berkshire Hathaway Inc, Sells The Mosaic Co, Apple Inc, Alphabet Inc
GuruFocus Article or News written by insider and the topic is about:
Kore Private Wealth LLC Buys Invesco Russell 1000 Dynamic Multifactor ETF, Coinbase Global Inc, Chevron Corp, Sells iShares Gold Trust, , PowerShares QQQ Trust Ser 1
GuruFocus Article or News written by insider and the topic is about:
Pfizer and Biontech submit vaccine booster data in US, poorer nations fall behind
Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) have submitted phase 1 data to the US regulator on a third 'booster shot' of their COVID-16 vaccine.
U.S. administers 357.29 million doses of COVID-19 vaccines
U.S. administers 357.29 million doses of COVID-19 vaccines – CDC
Pfizer Prices $1.0 Billion Sustainability Bond
Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
The
Pfizer Prices $1.0 Billion Sustainability Bond
Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
The
Pfizer Prices $1.0 Billion Sustainability Bond
Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
The
Pfizer Prices $1.0 Billion Sustainability Bond
Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
The
Pfizer Prices $1.0 Billion Sustainability Bond
Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
The
Pfizer Prices $1.0 Billion Sustainability Bond
Pfizer Prices $1.0 Billion Sustainability Bond | Nachricht | finanzen.net
Banks are already bracing for a September leveraged buyout boom
Banks are increasingly selling off short-term loans they made to fund leveraged buyouts, a sign that they’re freeing up capacity to lend even more in the coming months. Lenders are distributing $7.8 billion of such loans for the leveraged buyout of Medline Industries Inc., the biggest since the global financial crisis. Wells Fargo is selling a $1.475 billion short-term […]
Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster
Data from an early-stage study shows that a third vaccine dose offers a higher level of protection, the companies say.
BioNTech-Aktie knickt ein: BioNTech/Pfizer reichen erste Daten zur Auffrischungsimpfung bei FDA ein
Das deutsche Unternehmen BioNTech und sein US-Partner Pfizer haben erste Daten für die Zulassung einer Auffrischungsimpfung gegen das Coronavirus bei der US-Arzneimittelbehörde FDA eingereicht. 16.08.2021
Boyd Gaming : to Host Public COVID-19 Vaccination Sites in August
LAS VEGAS-To help in the ongoing fight against the COVID-19 pandemic, Boyd Gaming will host four COVID-19 vaccination sites at its properties across the Las Vegas Valley later this month.
… | August 16, 2021
Pfizer submits initial data for COVID-19 vaccine booster authorization
Pfizer Inc and its German partner BioNTech SE have submitted to U.S. regulators the initial data from an early-stage trial toward seeking authorization of a…
Pfizer, BioNTech File Initial Data to FDA to Support Covid-19 Vaccine Booster Dose
By Colin Kellaher
Pfizer Inc. and BioNTech SE on Monday said they have submitted Phase 1 data to the U.S. Food and Drug Administration to support the evaluation of a booster dose of their… | August 16, 2021
Carts Lined Up For Retail Earnings, But Foreign Affairs First In Checkout Line
Stocks Analysis by TD Ameritrade (JJ Kinahan) covering: S&P 500, Bank of America Corp, Microsoft Corporation, Cisco Systems Inc. Read TD Ameritrade (JJ Kinahan)'s latest article on Investing.com